DiaSorin

Did you know that viral meningitis can be caused by the herpes simplex virus (HSV 1 & 2) and varicella-zoster virus (VZV)?  Since bacterial and viral infections can display similar symptoms, fast and accurate detection is critical for pathogen identification and early treatment of this potentially life-threatening infection. Learn more about Diasorin’s Simplexa® HSV 1 & 2 Direct and Simplexa® VZV Direct assays, which are the only FDA cleared targeted tests for CSF samples. Fast and accurate detection can make all the difference.  Visit our website to learn more about our tests: https://hubs.li/Q02M4F250 #DefeatMeningitis #WorldMeningitisDay2024 #Diasorin

Did you know that group B Streptococcus (GBS) bacteria is a leading cause of bacterial meningitis in newborns? According to the CDC, there are still over 28,000 cases of invasive GBS disease that occur in the US each year across all ages, with GBS bacteria continuing to be a leading cause of meningitis and bloodstream infections in newborns under three months old. Diasorin continues its commitment to improving the quality of life for families with the Simplexa® GBS Direct assay, which demonstrates excellent clinical agreement against traditional culture methods and offers an efficient and effective solution for identifying GBS-positive mothers.  Learn more about World Meningitis Day: https://hubs.li/Q02M4yPW0  For more information about Simplexa® GBS Direct, visit our website: https://hubs.li/Q02M4BFC0 #WorldMeningitisDay2024 #DefeatMeningitis #Diasorin

The ACEP24 event was a tremendous success! We want to extend our gratitude to everyone who visited our booth and participated in our Expert Theater discussion. The engagement of current and future emergency medicine leaders was truly inspiring. Our distinguished panelists shared their experiences with LIAISON® MeMed BV® to a packed room. If you missed the event, a recording will be available on the ACEP website for attendees to view. We are already looking forward to exhibiting again next year! #acep24 #diagnosticstewardship #emergencymedicine #outpaceinfection

📌 The educational and clinical Global #TB Summit 2024 is almost here! Haven't registered yet? Secure your spot at the event that's shaping the future of TB management! 👉 https://lnkd.in/ej4x8kRx ✅ With the latest #tuberculosis (TB) research, over 35 expert talks, thousands of attendees and inspiring TB stories, it's the event you can’t miss. Here are the top 3 reasons to join us.

You're invited to attend an informative session at #SCASM2024 on October 4th from 7:45 a.m. - 8:45 a.m. at the Hyatt Regency in room Ocean Beach 1! In our session titled “New Molecular IVDs from Diasorin - Customizable Syndromic Testing with LIAISON PLEX® & Testing Patients for C. auris Colonization with Simplexa® Direct,” attendees will hear Dr. Sukantha Chandrasekaran and Dr. Michelle Tabb discuss the significant public health threat posed by C. auris, and introduce new specialized molecular testing. Come by Booth # 109 and explore the latest in targeted and syndromic molecular testing solutions. We look forward to connecting with you! Learn more about our molecular offerings here - https://hubs.li/Q02RJlDd0 #Candidaauris #LIAISONPLEX 

Did you know that an average of 1.7 million Americans are diagnosed with sepsis annually? Unfortunately, an estimated 350,000 of those cases prove to be fatal each year.  Fortunately, sepsis is a preventable condition. Remember to wash your hands often, stay updated on vaccinations, and keep any wounds covered until they heal completely. Together, we can raise awareness, engage in good medical hygiene, and save lives.  Learn more about sepsis with the CDC: For patients: https://hubs.li/Q02Rw_FF0 For healthcare providers: https://hubs.li/Q02Rw_GC0 #SepsisAwarenessMonth #Sepsis #SAM2024 #SepsisEducation

We are building on our legacy blood culture portfolio with the submission of the LIAISON PLEX® Gram-Negative Blood Culture Assay on the sample-to-answer LIAISON PLEX® System. Gram-negative bacteremia can lead to sepsis and occurs in approximately 30% of positive blood cultures. Optimized treatment is crucial for saving patients’ lives, and assays built with our proprietary NanoGrid technology have been at the forefront of helping clinicians make critical therapeutic decisions in hours, not days.

𝗢𝗿𝗶𝗲𝗻𝘁𝗶𝗲𝗿𝘂𝗻𝗴 𝗶𝗺 𝗣𝗮𝗿𝗮𝗴𝗿𝗮𝗳𝗲𝗻𝗱𝘀𝗰𝗵𝘂𝗻𝗴𝗲𝗹 𝗱𝗲𝗿 𝗜𝗩𝗗𝗥-𝗩𝗲𝗿𝗼𝗿𝗱𝗻𝘂𝗻𝗴 Das ursprüngliche Ziel der EU-Verordnung über In-vitro-Diagnostika (IVDR) war es, die Sicherheit und Innovation in der Diagnostik zu erhöhen. Doch die Behörden erreichten leider eher das Gegenteil: Die komplexen Vorgaben führten bei vielen Verantwortlichen in der Branche zu starker Verunsicherung. Aus diesem Grund luden wir Prof. Dr. Holger F. Rabenau von der Goethe-Universität Frankfurt am Main ein, der den Teilnehmenden des Diasorin Symposiums 2024 mehr Durchblick im Dickicht der Paragrafen verschaffte. In der Aufzeichnung seines detailreichen Vortrags erfahren auch Sie mehr über:  - die umfangreichen Anforderungen der IVDR - die Auswirkungen der Verordnung auf die Entwicklung von Labortests  - Strategien für eine IVDR-konforme Validierung - die Umsetzung der IVDR mit praktischen Tipps und Vorlagen für Ihr Labor Sind Sie interessiert?  Dann rufen Sie hier kostenlos das 35-minütige Vortragsvideo ab:  https://lnkd.in/dRetRj4U #IVDR #EUVerordnung #Diagnostik #Medizinprodukte #Labortests #Innovation #Diasorinsymposium

We’d like to thank everyone who visited our booth and attended our webinars at Labroots Microbiology Virtual Week!  We appreciate you taking the time to explore our latest offerings and learn more about our highly flexible testing solutions, including the next-generation LIAISON PLEX® System, the LIAISON PLEX® Respiratory Flex Assay, and the Simplexa® C. auris Direct kit. Did you miss our webinars? Access all the content you missed, now available to view on-demand on the Labroots website: https://hubs.li/Q02PNrzC0 1. Customizing Syndromic Respiratory Panels: Maximizing Patient Care through Flexible Testing Strategies 2. The Fungus Among Us - Detecting Candida auris Colonization and Yeast Bloodstream Infections

Join Diasorin in recognizing Fungal Disease Awareness Week (FDAW). As fungal infections, including C. auris infection, continue to rise around the world, this week provides a valuable opportunity to keep up-to-date on fungal disease awareness and support testing efforts worldwide.  When it comes to preventing the spread of life-threatening fungal infections, accessible and actionable detection is key. Learn how effective C. auris detection supports diagnostic stewardship in our recent Labroots webinar. Visit the Labroots Microbiology Virtual Event to watch "The Fungus Among Us - Detecting Candida auris Colonization and Yeast Bloodstream Infections" webinar on-demand. https://hubs.li/Q02Qw8DF0 #FungalWeek24 #Awareness #DiagnosticStewardship